RxDoctor Payments Data

Daniel Bennett, MD

Retina Specialist · Raleigh, NCNPI 1376715565

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $102,358 of the $126,183 with a category attached, or 81.1%. Genentech USA, Inc. accounts for 91.3% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $30,582 and has fallen 89.1% since, to $3,346 in 2025. Among retina specialist clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$126,183in general payments, 2019–2025

Across 225 payments — averaging $560.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech USA, Inc.$115K
  • Astellas Pharma US Inc$7K
  • Regeneron Healthcare Solutions, Inc.$1K
  • Alcon$797
  • Novartis$337
  • Apellis Pharmaceuticals, Inc.$309
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$7,0426%
  • Speaking & faculty fees$102,35881%
  • Travel & lodging$8,3077%
  • Food & beverage$8,4567%
  • Gifts$190%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$126,183 in reported general payments places this provider in the 95th percentile of 34 retina specialist providers in North Carolina.

See all retina specialist providers in North Carolina

Medicare billing

Part B allowed, 2024
$4,781,742
Medicare patients
1,224
Services billed
29,456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate184$6,791
Fluorometholone11$1,282
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat59$785
Tobramycin81$407
Timolol Maleate25$325
Latanoprost64$302
Brimonidine Tartrate18$198

Paid to pharmacies, not to this prescriber.

Other retina specialist in Raleigh

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →